Aardvark Therapeutics (NASDAQ:AARD) CEO Buys $96,600.00 in Stock
MarketBeat
Aardvark Therapeutics, Inc. (NASDAQ:AARD - Get Free Report) CEO Tien-Li Lee purchased 10,000 shares of the firm's stock in a transaction dated Monday, September 15th. The stock was acquired at an average cost of $9.66 per share, with a total value of $96,600.00. Following the completion of the acquisition, the chief executive officer directly owned 1,543,384 shares in the company, valued at approximately $14,909,089.44. This trade represents a 0.65% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
NASDAQ:AARD